Your browser doesn't support javascript.
loading
Interstitial Lung Disease That Occurred during Treatment with Etanercept (Enbrel(R)) of Psoriasis Patients / 대한피부과학회지
Korean Journal of Dermatology ; : 709-712, 2013.
Artículo en Coreano | WPRIM | ID: wpr-91560
ABSTRACT
Etanercept is widely used to treat autoimmune rheumatic, digestive, and dermatologic diseases such as psoriasis. It acts as a competitive inhibitor of tumor necrosis factor (TNF)-alpha and has acceptable safety and tolerability profiles. However, patients occasionally experience serious adverse effects such as infection, malignancy, cardiovascular events, and pulmonary disease. A 43-year-old man with a 10-year history of psoriasis presented with cough and exertional dyspnea that had developed 4 months after the initial etanercept administration. His symptoms continued to aggravate, and chest radiography and high-resolution computed tomography showed a diffuse reticulonodular infiltrate and ground-glass attenuation. As these clinical and radiologic findings suggested drug induced interstitial lung disease, we withdrew etanercept and initiated oral prednisolone treatment. The patient showed gradual improvement of the disease. Interstitial lung disease, although rare, is a potentially fatal adverse effect of TNF-alpha inhibitor treatment. Therefore, we recommend considering the possibility of interstitial lung disease in patients suffering from pulmonary symptoms who are taking TNF-alpha inhibitors.
Asunto(s)

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Psoriasis / Estrés Psicológico / Tórax / Inmunoglobulina G / Prednisolona / Factor de Necrosis Tumoral alfa / Receptores del Factor de Necrosis Tumoral / Enfermedades Pulmonares Intersticiales / Tos / Disnea Límite: Adulto / Humanos Idioma: Coreano Revista: Korean Journal of Dermatology Año: 2013 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Psoriasis / Estrés Psicológico / Tórax / Inmunoglobulina G / Prednisolona / Factor de Necrosis Tumoral alfa / Receptores del Factor de Necrosis Tumoral / Enfermedades Pulmonares Intersticiales / Tos / Disnea Límite: Adulto / Humanos Idioma: Coreano Revista: Korean Journal of Dermatology Año: 2013 Tipo del documento: Artículo